Back in 2016, NSF Pharma’s global vice-president of pharma biotech and medical devices spent time with a company struggling on every front. Compliance was poor, productivity at an all-time low and products were coming off-patent.

They were facing a revenue cliff. Every dollar spent had to be justified and 35% savings made. Anxiety permeated the four-day budget meeting where departmental heads made their case for a slice of the ever-diminishing budget pie. Inevitably, there were winners and losers.

Download this free white paper to find out how Martin Lush advised the company to convince leadership to spend more on training and keep critical programmes at the top of the list of budget priorities.